Clinic of Neurosurgery, Università Politecnica delle Marche, Azienda Ospedali Riuniti, Ancona, Italy.
Clinic of Neurosurgery, Università Politecnica delle Marche, Azienda Ospedali Riuniti, Ancona, Italy.
World Neurosurg. 2020 Dec;144:e1-e8. doi: 10.1016/j.wneu.2020.03.201. Epub 2020 Apr 18.
Atypical meningiomas are characterized by a high rate of recurrence and shorter overall survival (OS) compared with grade I meningioma. Predictive parameters for OS and recurrence-free survival (RFS) are controversial.
Patient age, sex, preoperative symptoms, tumor localization, size, Simpson grade, postoperative complications, extent of resection, number of mitoses, MIB1 proliferation index, brain invasion, postoperative radiotherapy, and clinical outcome (Karnofsky performance scale [KPS] postoperatively and at long-term follow-up) were evaluated. Data regarding recurrence rate, mortality, OS, and RFS at 1-, 3-, and 5-year follow-up were also collected. Median follow-up was 76 months; all patients had at least 3 years of follow-up.
Between 2007 and 2017, 73 patients underwent surgery for atypical meningiomas (World Health Organization grade II) at 2 centers. Preoperative KPS score >80 as well as 1-month, 6-month, and 1-year follow-up KPS scores were related to better OS. Postoperative complications did not modify OS and RFS. Gross total removal (Simpson grade I, II) was achieved in 80.8% of patients. RFS was statistically influenced by extent of resection (P = 0.002). MIB1 proliferation index >8 was a negative predictive factor for recurrence at univariate and multivariate analysis (P = 0.001 and P = 0.021). Radiotherapy was statistically related to a worse outcome. The incidence of recurrence was 38%. RFS was 98.6% at 1-year follow-up, 81.1% at 3 years, and 57.5% at 5 years. All patients were alive at 1-year follow-up. OS was 90.5% at 3-year follow-up and 78.8% at 5-year follow-up.
Despite some limitations, our study demonstrates that aggressive surgical treatment achieving a gross total removal is a positive predictive parameter for RFS as well as a good clinical outcome (KPS score >80) and is related to a longer OS.
与 I 级脑膜瘤相比,非典型脑膜瘤的复发率较高,总生存期(OS)较短。OS 和无复发生存期(RFS)的预测参数存在争议。
评估患者年龄、性别、术前症状、肿瘤定位、大小、辛普森分级、术后并发症、切除程度、有丝分裂数、MIB1 增殖指数、脑侵犯、术后放疗以及临床结果(术后和长期随访的卡诺夫斯基表现量表[KPS])。还收集了复发率、死亡率、OS 和 RFS 在 1、3 和 5 年随访时的数据。中位随访时间为 76 个月;所有患者的随访时间均至少为 3 年。
2007 年至 2017 年间,2 个中心的 73 例患者因非典型脑膜瘤(世界卫生组织 II 级)接受了手术治疗。术前 KPS 评分>80 以及术后 1 个月、6 个月和 1 年的 KPS 评分与更好的 OS 相关。术后并发症未改变 OS 和 RFS。80.8%的患者达到了大体全切除(辛普森分级 I、II)。RFS 在统计学上受切除程度的影响(P=0.002)。MIB1 增殖指数>8 是单变量和多变量分析中复发的负预测因素(P=0.001 和 P=0.021)。放疗在统计学上与较差的结果相关。复发率为 38%。RFS 在 1 年随访时为 98.6%,3 年时为 81.1%,5 年时为 57.5%。所有患者在 1 年随访时均存活。OS 在 3 年随访时为 90.5%,在 5 年随访时为 78.8%。
尽管存在一些限制,但我们的研究表明,积极的手术治疗实现大体全切除是 RFS 以及良好临床结果(KPS 评分>80)的阳性预测参数,并与较长的 OS 相关。